/Investor DB

Rex Health Ventures — 2020 Investments

1 investments dated 2020 · listed companies and verified rows first · show all

BioStable Science & EngineeringinFeb 2020

Cardiovascular device company developing HAART aortic valve repair technologies as an alternative to valve replacement.

Austin, US

John Wheeler(Executive Officer, Director)Joe Cunningham(Director)David Adair(Director)David Strong(Director)

Co-investorsLouisiana FundsOrlando Health Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.